Apogee Therapeutics, Inc. (APGE)
Healthcare
Biotechnology
134.10 $
-0.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Apogee Therapeutics, Inc. (APGE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -227 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -16 | -75 | -171 | -227 | |
| – | 0.0 | 0.2 | 1.4 | |
| 2.1 | 6.1 | 23 | 46 | |
| 9.8 | 6.1 | -2.0 | -15 | |
| 0.0 | 0.2 | 1.2 | 5.1 | |
| – | -274 | -300 | -180 | |
| 168 | 315 | 495 | 396 | |
| 152 | -33 | 23 | -11 | |
| -16 | -75 | -172 | -233 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.